New cell therapy injection enters final testing for severe eczema
Disease control
Not yet recruiting
This study is testing whether an experimental injection called ADSTEM can help control moderate-to-severe atopic dermatitis (eczema) in adults. Researchers will compare ADSTEM against a placebo injection in 286 participants whose eczema hasn't responded well to standard treatment…
Phase: PHASE3 • Sponsor: EHL Bio Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC